The largest database of trusted experimental protocols

Sulfo sda

Manufactured by Thermo Fisher Scientific

Sulfo-SDA is a water-soluble, amine-reactive, and non-membrane-permeable crosslinking reagent. It is used for covalent attachment of proteins or other macromolecules to amine-containing surfaces.

Automatically generated - may contain errors

6 protocols using sulfo sda

1

Covalent Mapping of IGF-1 Binding to Imp-L2

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human IGF-1 or des(63-70)-IGF-1were modified with sulfo-succinimidyl 4,4′-azidopentanoate (Sulfo-SDA, ThermoFisher). Proteins (0.2 mM, about 100 μg) in PBS were incubated with 2 mM Sulfo-SDA for 2 h on ice. The reaction was stopped by addition of a quenching Tris/HCl buffer (pH 8) to a final 40 mM concentration. The mixture was incubated 5 min at room temperature. Modified proteins in PBS (final concentration about 0.1 mM) were separated from unreacted crosslinker using Zeba Spin Desalting Column (ThermoFisher).
Ligands (about 100 μg, 10–20 nmol) modified with Sulfo-SDA on their Lys and N-terminal amines were incubated with recombinant Imp-L2 (76 μg, about 3 nmol) overnight at 4°C. Proteins were photocrosslinked using irradiation at 365 nm for 5 min in a distance 1 cm from the light source (UVP Black-Ray B-100AP Lamp, Fisher Scientific).
Samples after photocrosslinking were analyzed using SDS-PAGE (14% gel). The extent of crosslinking of IGF-1 and des(63-70)-IGF-1 to Imp-L2 was determined using western-blotting with anti-IGF-1 antibody (1C5-1A2) (MA1-088, ThermoFisher). Mixture of proteins after photocrosslinking was separated on SDS-PAGE and stained with Coomassie R250. Bands containing the unmodified proteins and bands containing the crosslinked product were excised.
+ Open protocol
+ Expand
2

Crosslinking of Target Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
T0975 and T0987 had been forwarded to the Rappsilber Laboratory as previously thawed-frozen samples by Esben Trabjerg from the Leitner Laboratory at ETH Zurich.
Crosslinking was carried out according to previously described procedures 9 (link)-11 (link). Briefly, target proteins were crosslinked separately using sulfosuccinimidyl 4,4’-azipentanoate (sulfo-SDA) (Thermo Scientific Pierce, Rockford IL) in a two-stage reaction (using eight different crosslinker-to-protein ratios: 0.13:1, 0.19:1, 0.25:1, 0.38:1, 0.5:1, 0.75:1, 1:1 and 1.5:1 (w/w), a protein concentration of 0.5 mg/mL and using 20 μg protein aliquots), with reaction of the NHS-ester firstly, subsequently followed by UV photoactivation at 365 nm, from a UVP CL-1000 UV Crosslinker (UVP Inc.).
Following crosslinking, reaction conditions were mixed and resulting crosslinked proteins separated by electrophoresis using NuPAGE 4-12% Bis-Tris gels, with MES SDS running buffer and staining using InstantBlue™ (Expedeon). Protein gel bands were digested using trypsin via standard protocols 12 (link). Resulting peptides were desalted using StageTips 13 (link),14 (link).
+ Open protocol
+ Expand
3

Blood Serum Collection and Preservation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cross-linking reagent sulfo-SDA was purchased from Thermo Scientific Pierce (Rockford, IL). Human blood serum was acquired from a healthy male donor after informed consent, in accordance with standard institutional ethical procedures at the University of Edinburgh, School of Biological Sciences. Immediately following collection (50 ml total volume split over 2× Falcon 50 ml Conical Centrifuge Tubes), blood serum was isolated from the whole blood sample without anti-coagulants, by centrifugation. Whole blood was allowed to clot by leaving it undisturbed at room temperature for 30 min. The clot was removed by centrifuging at 1900 × g for 10 min at 4 °C. The resulting supernatant was immediately apportioned into 1.5 ml Eppendorf Tubes as 0.5 ml aliquots, which were flash frozen using liquid nitrogen and stored in a −80 °C freezer. Protein concentration was estimated at 80 mg/ml using a Bradford protein assay.
+ Open protocol
+ Expand
4

Cross-linking and MS Identification of Protein Complexes

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cross-linker sulfo-SDA (sulfosuccinimidyl 4,4′-azipentanoate) (Thermo Scientific) was dissolved in cross-linking buffer (10 mM HEPES pH 7.8, 150 mM NaCl, 4 mM MgCl2, 0.5 mM TCEP) to 100 mM before use. The labelling step was performed by incubating 18 μg aliquots of the complex at 1 mg/mL with 2, 1, 0.5, 0.25, 0.125 mM sulfo-SDA, added, respectively, for an hour. The samples were then irradiated with UV light at 365 nm, to form cross-links, for 20 min and quenched with 50 mM NH4HCO3 for 20 min. All steps were performed on ice. Reaction products were separated on a Novex Bis-Tris 4–12% SDS−PAGE gel (Life Technologies). The gel band corresponding to the cross-linked complex was excised and digested with trypsin (Thermo Scientific Pierce) [116 (link)] and the resulting tryptic peptides were extracted and desalted using C18 StageTips [117 (link)]. Eluted peptides were fractionated on a Superdex Peptide 3.2/300 increase column (GE Healthcare) at a flow rate of 10 μL/min using 30% (v/v) acetonitrile and 0.1% (v/v) trifluoroacetic acid as mobile phase. 50 μL fractions were collected and vacuum-dried.
+ Open protocol
+ Expand
5

Crosslinking and Fractionation of Elongator Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
85 μg of ScElongator complex at 2.22 μM concentration was crosslinked with sulfo-SDA (sulfosuccinimidyl 4,4′-azipentanoate, Thermo Scientific) at 1:500 and 1:1000 sample:crosslinker molar ratios. The reaction was incubated at room temperature for 60 min irradiated with UV light at 365 nm using a Luxigen34 LZ1 LED emitter (Osram Sylvania Inc.) for 10 s, and quenched with a final concentration of 50 mM ammonium bicarbonate (ABC). The crosslinked complex was separated from single subunits on a Novex Bis–Tris 4–12% SDS-PAGE gel (Life Technologies). Gel pieces containing the crosslinked complex were excised. The sample was reduced with DTT and free sulfhydryl groups were alkylated using iodoacetamide (74 (link)). Proteins were digested overnight at 37°C with 1 μg trypsin (Thermo Scientific Pierce) per 20 μg of protein sample. The digested peptides were recovered and desalted using C18 StageTips (75 (link)). The eluates of the StageTips were pooled and fractionated by size exclusion chromatography (SEC) using a Superdex™ 30 Increase 3.2/300 column (GE Healthcare) and a mobile phase consisting of 30% v/v ACN and 0.1% v/v trifluoric acid at a flow rate of 10 μl/min. The first six fractions (50 μl each) containing peptides were collected and the solvent was removed using a vacuum concentrator.
+ Open protocol
+ Expand
6

Crosslinking and Mass Spectrometry of Elongator Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
85 µg of HsElongator at 1.4 µM concentration were crosslinked with sulfo-SDA (sulfosuccinimidyl 4,4′-azipentanoate, Thermo Scientific) at 1:500 and 1:1000 protein:crosslinker molar ratios. For MmElongator, 60 µg at 5.0 µM concentration were used. After incubation at room temperature for 60 min, the reaction mix was irradiated with UV light at 365 nm using a Luxigen34 LZ1 LED emitter (Osram Sylvania Inc.) for 10 s. 50 mM ammonium bicarbonate was added to quench the reaction. SDS-PAGE was used to separate the crosslinked complexes from single subunits (Novex Bis-Tris 4–12% SDS−PAGE gel, Life Technologies), and gel sections containing the crosslinked complex were excised. Dithiothreitol reduced the sample and iodoacetamide alkylated free sulfhydryl groups70 (link). Proteins were digested using 1 µg trypsin (Thermo Scientific Pierce) per 20 µg of protein sample. The resulting peptides from the digestion were subjected to desalting using C18 StageTips71 (link).
The eluates from the StageTips were fractionated via size exclusion chromatography (SEC) using a Superdex™ 30 Increase 3.2/300 column (GE Healthcare). A mobile phase comprising 30% (v/v) acetonitrile (ACN) and 0.1% trifluoroacetic acid at a flow rate of 10 µl/min was used. The first six 50 µL fractions containing peptides were collected and the solvent was removed using a vacuum concentrator.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!